article_metadata: Nobuhiko Seki Maika Natsume Ryosuke Ochiai Terunobu Haruyama Masashi Ishihara Yoko Fukasawa Takahiko Sakamoto Shigeru Tanzawa Ryo Usui Takeshi Honda Shuji Ota Yasuko Ichikawa Kiyotaka Watanabe
article_metadata: 10.1159/000493088
article_metadata: Case Rep Oncol
article_metadata: 2019 Jan 21;12(1):91-97.
article_metadata: bevacizumab egfr mutation erlotinib lung cancer met amplification
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/30792648/
article_metadata: Case Reports
article_metadata: PMC6381877
article_metadata: 30792648
article_metadata: Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy
article_metadata: 2019